Innovative and Applied Emerging Technologies in Biospecimen Science (R33)
Purpose.
This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science.
The overall goal is to develop and evaluate technologies capable of interrogating or maximizing the quality and utility of biospecimens for molecular analyses with minimal invasiveness or compromise to donor/patient health.
This FOA will also support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions.
Projects must clearly demonstrate potential to produce a major impact in the area of biospecimen science.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available.
To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs.
See NOT-CA-09-00 7.
This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exceptionally innovative, high risk, original and/or unconventional exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies for biospecimen science.
The overall goal is to develop and evaluate technologies capable of interrogating or maximizing the quality and utility of biospecimens for molecular analyses with minimal invasiveness or compromise to donor/patient health.
This FOA will also support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions.
Projects must clearly demonstrate potential to produce a major impact in the area of biospecimen science.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available.
To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs.
See NOT-CA-09-00 7.
Related ProgramsDepartment of Health and Human Services
Department of Health and Human Services
Department of Health and Human Services
Cancer Cause and Prevention Research
Department of Health and Human ServicesCancer Detection and Diagnosis Research
Department of Health and Human ServicesDepartment of Health and Human Services
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $1,000,000
Office: National Institutes of Health
Estimated Funding: $1,000,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-005.html
Additional Information of Eligibility:
Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government; Non-domestic (non-U.S.) Entities (Foreign Organizations); U. S. Territory or Possession.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-09-005.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2008-12-15
Application Due Date:
2009-09-30
Archive Date:
2009-10-31
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
